Clinical Trial

Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine

Name: Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine — clinical trial record (NCT07758972)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LTBNG601

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The main goal of this trial is to evaluate the safety and immunogenicity of the candidate N. gonorrhoeae vaccine, LTB-NG6.

Trial Details

NCT Number	NCT07758972
Lead Sponsor	LimmaTech Biologics AG Collaborators: Nuvisan, Germany, Wellcome Trust, German Federal Ministry of Education and Research, Novo Nordisk Foundation
Conditions	Neisseria Gonorrhea
Enrollment	142 participants
Start Date	2026-08-19
Primary Completion	2027-04-26 (estimated)
Study Completion	2027-09-23 (estimated)
Updated on ClinicalTrials.gov	2026-08-11